Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty
Status:
Not yet recruiting
Trial end date:
2022-11-30
Target enrollment:
Participant gender:
Summary
This trial is to investigate the safety and potential therapeutic efficacy of allogeneic
administration of umbilical cord-derived MSCs (UC-MSCs) in combination with standard frailty
treatment in Vietnam
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Vinmec Research Institute of Stem Cell and Gene Technology